LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Abstract Long non-coding RNA-myocardial infarction-associated transcript (lncRNA-MIAT) has been reported to play an important role in the development of multiple cancers. However, the biological roles of MIAT in liver fibrosis are still unknown. In this study, the expression of MIAT is up-regulated...

Full description

Bibliographic Details
Main Authors: Yating Zhan, Qiqi Tao, Qishan Meng, Rongrong Zhang, Lifan Lin, Xinmiao Li, Lei Zheng, Jianjian Zheng
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-023-04670-z
_version_ 1827388225089437696
author Yating Zhan
Qiqi Tao
Qishan Meng
Rongrong Zhang
Lifan Lin
Xinmiao Li
Lei Zheng
Jianjian Zheng
author_facet Yating Zhan
Qiqi Tao
Qishan Meng
Rongrong Zhang
Lifan Lin
Xinmiao Li
Lei Zheng
Jianjian Zheng
author_sort Yating Zhan
collection DOAJ
description Abstract Long non-coding RNA-myocardial infarction-associated transcript (lncRNA-MIAT) has been reported to play an important role in the development of multiple cancers. However, the biological roles of MIAT in liver fibrosis are still unknown. In this study, the expression of MIAT is up-regulated during liver fibrosis. Silencing MIAT leads to the suppression of hepatic stellate cell (HSC) proliferation and collagen expression. Double immunofluorescence analysis additionally demonstrates that MIAT inhibition leads to the suppression of type I collagen and α-SMA in vitro. In vivo, MIAT knockdown contributes to the inhibition of fibrosis progression and collagen accumulation. MIAT is confirmed as a target of miR-3085-5p, and the co-location of MIAT and miR-3085-5p is found in HSC cytoplasm. Interestingly, there is a negative correlation between MIAT expression and miR-3085-5p level in cirrhotic patients as well as activated HSCs. In addition, the effects of MIAT inhibition on HSC inactivation are blocked down by miR-3085-5p inhibitor. YAP is a target of miR-3085-5p. Reduced YAP caused by loss of MIAT is reversed by miR-3085-5p inhibitor. Notably, YAP knockdown results in the suppression of MIAT-mediated epithelial-to-mesenchymal transition (EMT) process. In conclusion, we demonstrate that MIAT enhances the activation of HSCs, at least in part, via miR-3085-5p/YAP/EMT signaling pathway.
first_indexed 2024-03-08T16:14:23Z
format Article
id doaj.art-71bfb92c00fb41159696c81ccc2edb13
institution Directory Open Access Journal
issn 2399-3642
language English
last_indexed 2024-03-08T16:14:23Z
publishDate 2023-03-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj.art-71bfb92c00fb41159696c81ccc2edb132024-01-07T12:39:44ZengNature PortfolioCommunications Biology2399-36422023-03-016111110.1038/s42003-023-04670-zLncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transitionYating Zhan0Qiqi Tao1Qishan Meng2Rongrong Zhang3Lifan Lin4Xinmiao Li5Lei Zheng6Jianjian Zheng7Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityKey Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical UniversityAbstract Long non-coding RNA-myocardial infarction-associated transcript (lncRNA-MIAT) has been reported to play an important role in the development of multiple cancers. However, the biological roles of MIAT in liver fibrosis are still unknown. In this study, the expression of MIAT is up-regulated during liver fibrosis. Silencing MIAT leads to the suppression of hepatic stellate cell (HSC) proliferation and collagen expression. Double immunofluorescence analysis additionally demonstrates that MIAT inhibition leads to the suppression of type I collagen and α-SMA in vitro. In vivo, MIAT knockdown contributes to the inhibition of fibrosis progression and collagen accumulation. MIAT is confirmed as a target of miR-3085-5p, and the co-location of MIAT and miR-3085-5p is found in HSC cytoplasm. Interestingly, there is a negative correlation between MIAT expression and miR-3085-5p level in cirrhotic patients as well as activated HSCs. In addition, the effects of MIAT inhibition on HSC inactivation are blocked down by miR-3085-5p inhibitor. YAP is a target of miR-3085-5p. Reduced YAP caused by loss of MIAT is reversed by miR-3085-5p inhibitor. Notably, YAP knockdown results in the suppression of MIAT-mediated epithelial-to-mesenchymal transition (EMT) process. In conclusion, we demonstrate that MIAT enhances the activation of HSCs, at least in part, via miR-3085-5p/YAP/EMT signaling pathway.https://doi.org/10.1038/s42003-023-04670-z
spellingShingle Yating Zhan
Qiqi Tao
Qishan Meng
Rongrong Zhang
Lifan Lin
Xinmiao Li
Lei Zheng
Jianjian Zheng
LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
Communications Biology
title LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
title_full LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
title_fullStr LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
title_full_unstemmed LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
title_short LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
title_sort lncrna miat activates hepatic stellate cells via regulating hippo pathway and epithelial to mesenchymal transition
url https://doi.org/10.1038/s42003-023-04670-z
work_keys_str_mv AT yatingzhan lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT qiqitao lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT qishanmeng lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT rongrongzhang lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT lifanlin lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT xinmiaoli lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT leizheng lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition
AT jianjianzheng lncrnamiatactivateshepaticstellatecellsviaregulatinghippopathwayandepithelialtomesenchymaltransition